Avanos Medical Inc
NYSE:AVNS
Avanos Medical Inc
NYSE:AVNS
Price:
19.58 USD
0.56%
Market Closed
Updated:
May 11, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
19.4
Current
15.6
Median
12.9
Industry
Higher
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=19.4
Enterprise Value
/
975.8m
EBITDA
50.3m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
Avanos Medical Inc
NYSE:AVNS
|
904.1m USD | 19.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.3T JPY | 23.1 | |
| CH |
|
Alcon AG
SIX:ALC
|
36.3B CHF | 18.3 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
190B DKK | 25.7 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
20.4B USD | 24.2 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
18.8B USD | 23.5 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
13.1T KRW | -113 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
61.2B CNY | 31.3 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 46.9 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 11.6 | |
| CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.4B USD | 15.5 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
8.2
2-Years Forward
EV/EBITDA
6.5
3-Years Forward
EV/EBITDA
6
You don't have any saved screeners yet
